Dyslipidemia in Juvenile Dermatomyositis

Area of Science:

• Pediatric Rheumatology
• Cardiovascular Health in Autoimmune Diseases
• Metabolic Syndrome in Chronic Illness

Background:

• Juvenile Dermatomyositis (JDM) is a rare autoimmune disease affecting children.
• Dyslipidemia is a known risk factor for cardiovascular disease.
• The relationship between dyslipidemia and disease activity in JDM is not well-established.

Purpose of the Study:

• To determine the prevalence of dyslipidemia in JDM patients.
• To investigate the association between dyslipidemia and indicators of JDM disease activity.
• To identify potential risk factors for dyslipidemia in this population.

Main Methods:

• Retrospective chart review of 142 JDM patients with fasting lipid profiles.
• Collection of clinical and laboratory markers of disease activity at lipid assessment.
• Statistical analysis to correlate lipid parameters with disease activity measures.

Main Results:

• High prevalence (72%) of abnormal or borderline lipid profiles in JDM patients.
• Low HDL and elevated triglycerides were the most common lipid abnormalities.
• Lower HDL levels significantly correlated with increased disease activity scores (DAS total, muscle, skin), neopterin, ESR, and vWF Ag.
• Treatment-naïve patients showed significantly lower HDL levels compared to those on medication.

Conclusions:

• JDM patients exhibit a high burden of dyslipidemia, closely linked to disease activity.
• Low HDL and elevated triglycerides are key lipid abnormalities in JDM.
• Annual lipid monitoring and early interventions are recommended for JDM patients.